Literature DB >> 25849424

Response to "in vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement".

Kota Iwahori1, Xiao-Tong Song2, Stephen Gottschalk3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25849424      PMCID： PMC4395792          DOI： 10.1038/mt.2015.37

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  6 in total

1.  Properties of the major component of a peptic digest of rabbit antibody.

Authors:  A NISONOFF; F C WISSLER; L N LIPMAN
Journal:  Science       Date:  1960-12-09       Impact factor: 47.728

2.  Transduction of antigen-presenting cells in the brain by AAV9 warrants caution in preclinical studies.

Authors:  John Forsayeth; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2015-04       Impact factor: 11.454

3.  Engager T cells: a new class of antigen-specific T cells that redirect bystander T cells.

Authors:  Kota Iwahori; Sunitha Kakarla; Mireya P Velasquez; Feng Yu; Zongzhen Yi; Claudia Gerken; Xiao-Tong Song; Stephen Gottschalk
Journal:  Mol Ther       Date:  2014-08-21       Impact factor: 11.454

4.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Authors:  U D Staerz; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 5.  Blinatumomab: a historical perspective.

Authors:  Dirk Nagorsen; Peter Kufer; Patrick A Baeuerle; Ralf Bargou
Journal:  Pharmacol Ther       Date:  2012-08-24       Impact factor: 12.310

6.  Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA x anti-CD3 diabodies from lentivirally transduced human lymphocytes.

Authors:  M Compte; B Blanco; F Serrano; A M Cuesta; L Sanz; A Bernad; P Holliger; L Alvarez-Vallina
Journal:  Cancer Gene Ther       Date:  2007-01-12       Impact factor: 5.987
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.